Amifostine

This classification denotes a cytoprotective agent with the molecular formula C5H15N2O3PS.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M487QF2F4V, chemically known as 2-((3-aminopropyl)amino)-ethanethiol, dihydrogen phosphate ester (9ci) but more generally known as amifostine, which bears US NIH Compound Identifier 2141. Amifostine most often comes in base, ethiofos, and hyrdate forms. European Medicines Agency schedules Amifostine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12846MIG. World Health Organization schedules amifostine in its Anatomical Therapeutic Chemical (ATC) Classification. AMIFOSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule amifostine under HS 29309085 and SITC 51549. As of Q4 2014, AMIFOSTINE remains US FDA's Preferred Term for this commodity. Amifostine bears US NLM identifiers UMLS ID C0591467 and NCI Concept Code C488. SMILES: S(P(=O)(O)O)CCNCCCN.